Market Tracker

10/23 8:08am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.6951
Data as of Oct 22
 -0.0168 / -2.36%
Today’s Change
0.65
Today|||52-Week Range
4.00
-24.85%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.71
Today’s open0.70
Day’s range-- - --
Volume181,676
Average volume (3 months)308,415
Market cap$43.2M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-34.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...+0.01+1.54%
PBMDPrima BioMed Ltd-0.02-2.03%
CASICASI Pharmaceuticals...+0.01+0.60%
BCLIBrainstorm Cell Ther...-0.10-2.69%
Data as of 10/22/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts